Toxic epidermal necrolysis due to omeprazole [9]

European Journal of Dermatology

Volumn 16, Issue 6, 2006, Pages 699-700

  Casacci, M ^a   Lebas, D ^a   Decamps, F ^a   Fourrier, F ^a   Delaporte, E ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; IMMUNOGLOBULIN; OMEPRAZOLE; PIPERACILLIN PLUS TAZOBACTAM;

ACUTE RESPIRATORY FAILURE; ADULT; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; CONJUNCTIVITIS; CORNEA LESION; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LETTER; MALE; MULTIPLE CYCLE TREATMENT; PSEUDOMONAS AERUGINOSA; SEPTICEMIA; SKIN BIOPSY; STOMACH ULCER; TOXIC EPIDERMAL NECROLYSIS;

ANTI-ULCER AGENTS; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; STOMACH ULCER;

EID: 33846807656     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2006.0018     Document Type: Letter

References (6)

1. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000; 115: 149-53.
2. Bégaud B, Evreux JC, Jouglard J, Lagier G. Unexpected or toxic drug reaction imputation. Actualization or the method used in France. Thérapie 1985; 40: 111-8.
3. Cockayne SE, Glet RJ, Gawkrodger DJ, McDonagh AJG. Severe erythrodermic reactions to the proton pump inhibitors omeprazole and lansoprazole. Br J Dermatol 1999; 141: 173-5.
4. Cox NH. Acute disseminated epidermal necrosis due to omeprazole. Lancet 1992; 340: 857.
5. Heaton NR, Edmonds EVJ, Francis ND, Bunker CB, Bowling JCR, Morar N. Fatal toxic epidermal necrolysis due to lansoprazole. Clin Exp Dermatol 2004; 29: 612-3.
6. Prins C, Kerdel FA, Padilla RS, et al. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003; 139: 20-32.